FilingReader Intelligence
Hester Biosciences consolidated profit jumps over 100%
August 4, 2025 at 01:39 PM UTC•By FilingReader AI
Hester Biosciences reported mixed Q1 FY26 results, with standalone divisional product sales falling 14% to INR63 crores due to delayed government immunization programs.
However, consolidated profit grew over 100%, driven by improved international operations. Hester Africa turned around significantly, recording INR5 crores profit on INR17 crores revenue, up from INR3 crores previously.
The Poultry Healthcare division achieved marginal 2% growth.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
BSE:HESTERBIO•Bombay Stock Exchange
News Alerts
Get instant email alerts when Hester Biosciences publishes news
Free account required • Unsubscribe anytime